The effects of formoterol, a long-acting 2 -adrenoceptor agonist, on mucociliary activity

Author： Lindberg S.   Khan R.   Runer T.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.285, Iss.3, 1995-10, pp. : 275-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-inflammatory effects of a short-acting and a long-acting 2 -adrenoceptor agonist in guinea pig skin

By Teixeira M.M.   Williams T.J.   Hellewell P.G.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite

Which long-acting 2-agonist is best? Formoterol vs salmeterol

By  

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

The Impact of Nonadherence to Inhaled Long-Acting β 2 -Adrenoceptor Agonist/Corticosteroid Combination Therapy on Healthcare Costs in Difficult-to-Control Asthma

By O'Neill Ciaran   Gamble Jacqui   Lindsay John T.   Heaney Liam G.  

Pharmaceutical Medicine, Vol. 25, Iss. 6, 2011-12 ,pp. : 379-385

Adis International

Access to resources Recommend Favorite

Long-acting 2-adrenoceptor agonists: increased risk of death?

By  

Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Combinations of a long-acting β2 agonist; is it BI-1744-CL?

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 11, 2007-11 ,pp. : 1401-1404

Informa Healthcare

Access to resources Recommend Favorite